PGEN
Precigen Inc
Price:  
1.37 
USD
Volume:  
1,393,069.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

PGEN WACC - Weighted Average Cost of Capital

The WACC of Precigen Inc (PGEN) is 8.1%.

The Cost of Equity of Precigen Inc (PGEN) is 9.20%.
The Cost of Debt of Precigen Inc (PGEN) is 7.00%.

Range Selected
Cost of equity 7.50% - 10.90% 9.20%
Tax rate 0.20% - 0.30% 0.25%
Cost of debt 7.00% - 7.00% 7.00%
WACC 7.3% - 8.9% 8.1%
WACC

PGEN WACC calculation

Category Low High
Long-term bond rate 3.9% 4.4%
Equity market risk premium 4.6% 5.6%
Adjusted beta 0.8 1.08
Additional risk adjustments 0.0% 0.5%
Cost of equity 7.50% 10.90%
Tax rate 0.20% 0.30%
Debt/Equity ratio 1 1
Cost of debt 7.00% 7.00%
After-tax WACC 7.3% 8.9%
Selected WACC 8.1%

PGEN's CAPM model and how its cost of Equity is calculated

The Cost of Equity reflects the return a company needs to deliver to shareholders to justify the risk of investing in its shares. It’s computed using the Capital Asset Pricing Model (CAPM), which blends the risk-free rate, the stock’s beta, and the market risk premium.

This method evaluates the stock’s risk compared to a safe investment and the market’s overall volatility.

Here’s how we figure out the cost of equity for PGEN:

cost_of_equity (9.20%) = risk_free_rate (4.15%) + equity_risk_premium (5.10%) * adjusted_beta (0.8) + risk_adjustments (0.25%)

We include the risk adjustments, which range from 0% to 1%, to keep our WACC conservatives, especially for companies traded in developing markets.